Dogwood Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Sell
483
-67
-12% -$14.4K 0.05% 95
2026
Q1
$120K Buy
550
+77
+16% +$17.1K 0.05% 108
2025
Q4
$108K Buy
473
+46
+11% +$10.5K 0.05% 106
2025
Q3
$98.9K Buy
427
+73
+21% +$14.9K 0.04% 105
2025
Q2
$67.2K Buy
354
+29
+9% +$5.39K 0.03% 109
2025
Q1
$68.1K Buy
325
+75
+30% +$14.6K 0.04% 108
2024
Q4
$44.5K Buy
250
+2
+0.8% +$368 0.02% 124
2024
Q3
$49K Buy
248
+2
+0.8% +$373 0.03% 117
2024
Q2
$42.3K Buy
246
+2
+0.8% +$331 0.03% 119
2024
Q1
$44.4K Buy
244
+2
+0.8% +$345 0.03% 128
2023
Q4
$37.5K Buy
+242
New +$35.3K 0.03% 128

Other funds holding ABBV

Dogwood Wealth Management's ABBV Position: Q2 2026 in Review

Dogwood Wealth Management reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $14.4K and leaving 483 shares worth $122K. The position accounts for 0.05% of the portfolio, ranked #95.

Dogwood Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Dogwood Wealth Management held 483 shares of AbbVie worth $122K as of Q2 2026.
  • Dogwood Wealth Management sold 67 AbbVie shares in Q2 2026, an estimated $14.4K.
  • AbbVie made up 0.05% of Dogwood Wealth Management's portfolio in Q2 2026, its #95 holding.
  • Dogwood Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.